02 Mar 2020
Led by General Atlantic, funding will expand novel scientific platform and advance proprietary pipeline of ImmTAX™ molecules into the clinic
(Oxfordshire, UK and Conshohocken, Pa. and Rockville, Md., US, 2 March 2020)Immunocore, a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune... Read more
